| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurogene Inc. (NGNE) has 3 insiders with recent SEC Form 4 filings, including 2 buys and 21 sells. NGNE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.34M | $43.62M | - | |
| CFO | 98.4K | $3.19M | - | |
| Other | 12.5K | $404.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2015 | Mitchell David Chilton | VP Global Regulatory &Quality | Buy | 3,575 | $17.81 | $63,670.75 | New | |
| Aug 12, 2015 | MacKenzie Lloyd | VP Technical Operations | Sale+OE | 35,887 | $18.67 | $670,010.29 | -100% | |
| Aug 12, 2015 | Alam Kamran | CFO, Vice President Finance | Sale+OE | 29,079 | $18.67 | $542,904.93 | -100% | |
| Aug 11, 2015 | Mitchell David Chilton | VP Global Regulatory &Quality | Buy | 1,600 | $24.36 | $38,976.00 | New | |
| Aug 11, 2015 | Johnson & Johnson59 | 10% Owner | Sell | 1,514,821 | $22.41 | $33,944,876.14 | -50.5% | |
| Aug 10, 2015 | Pfizer Inc | 10% Owner | Sell | 259,927 | $26.47 | $6,880,295.42 | -1.3% |